temozolomide has been researched along with Heart Diseases in 1 studies
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It may also allow a reduction in dosage and a decrease in systemic toxicity." | 1.35 | Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity. ( Bi, X; Dou, M; Huang, G; Zhang, N, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, G | 1 |
| Zhang, N | 1 |
| Bi, X | 1 |
| Dou, M | 1 |
1 other study available for temozolomide and Heart Diseases
| Article | Year |
|---|---|
Solid lipid nanoparticles of temozolomide: potential reduction of cardial and nephric toxicity.
Topics: Animals; Antineoplastic Agents, Alkylating; Chemical Phenomena; Chemistry, Physical; Chromatography, | 2008 |